Comments
Loading...
Galecto (NASDAQ:GLTO) Stock Quotes, Forecast and News Summary
Galecto Stock (NASDAQ: GLTO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Galecto (GLTO) stock?
You can purchase shares of Galecto (NASDAQ:GLTO) through any online brokerage.
Who are Galecto (GLTO) competitors?
Other companies in Galecto’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Vincerx Pharma (NASDAQ:VINC), Alzamend Neuro (NASDAQ:ALZN), Addex Therapeutics (NASDAQ:ADXN) and Coeptis Therapeutics (NASDAQ:COEP).
What is the forecast, or price target, for Galecto (GLTO) stock?
Galecto has a consensus price target of $8.50.
What is the current price for Galecto (GLTO)?
The stock price for Galecto (NASDAQ: GLTO) is $6.19 last updated November 19, 2024 at 4:18 PM EST.
Does Galecto (GLTO) pay a dividend?
There are no upcoming dividends for Galecto.
When is Galecto (NASDAQ:GLTO) reporting earnings?
Galecto’s Q3 earnings are confirmed for Friday, November 1, 2024.
Is Galecto (GLTO) going to split?
There is no upcoming split for Galecto.
What sector and industry does Galecto (GLTO) operate in?
Galecto is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.